Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations

British Journal of Surgery

Volumn 94, Issue 8, 2007, Pages 1009-1013

  Speake, D ^a   Evans, D G ^b   Lalloo, F ^b   Scott, N A ^c   Hill, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN;

ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CHILD; CHOLANGITIS; COLON POLYPOSIS; DEATH; DESMOID TUMOR; FEMALE; GENE MUTATION; HUMAN; INTESTINE FISTULA; INTESTINE OBSTRUCTION; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; URETER OBSTRUCTION;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; FEMALE; FIBROMATOSIS, AGGRESSIVE; GENES, APC; HUMANS; MALE; MESENTERY; MIDDLE AGED; MUTATION; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34547818180     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5633     Document Type: Article

References (24)

1. Arvanitis ML, Jagelman DG, Fazio VW, Lavery IC, McGannon E. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1990; 33: 639-642.
2. Clark SK, Neale KF, Landgrebe JC, Phillips RK. Desmoid tumours complicating familial adenomatous polyposis. Br J Surg 1999; 86: 1185-1189.
3. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum 1993; 36: 1059-1062.
4. Nugent KP, Spigelman AD, Williams CB, Talbot IC, Phillips RK. Follow-up in familial adenomatous polyposis. Lancet 1993; 341: 1225.
5. Bertario L, Russo A, Sala P, Eboli M, Giarola M, D'amico F et al. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. Int J Cancer 2001; 95: 102-107.
6. Caspari R, Friedl W, Mandl M, Moslein G, Kadmon M, Knapp M et al. Familial adenomatous polyposis: mutation at codon 1309 and early onset of colon cancer. Lancet 1994; 343: 629-632.
7. Friedl W, Caspari R, Sengteller M, Uhlhaas S, Lamberti C, Jungck M et al. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001; 48: 515-521.
8. Knudsen AL, Bulow S. Desmoid tumour in familial adenomatous polyposis. A review of literature. Fam Cancer 2001; 1: 111-119.
9. Knudsen AL, Bisgaard ML, Bulow S. Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2003; 2: 43-55.
10. Scott RJ, Froggatt NJ, Trembath RC, Evans DG, Hodgson SV, Maher ER. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 1996; 5: 1921-1924.
11. Sturt NJ, Gallagher MC, Bassett P, Philp CR, Neale KF, Tomlinson IP et al. Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 2004; 53: 1832-1836.
12. Davies DR, Armstrong JG, Thakker N, Horner K, Guy SP, Clancy T et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57: 1151-1158.
13. Lotfi AM, Dozois RR, Gordon H, Hruska LS, Weiland LH, Carryer PW et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis 1989; 4: 30-36.
14. Lynch HT, Fitzgibbons R Jr. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 1996; 91: 2598-2601.
15. Evans DG, Evans D, Hill J, Dudding T, Burn J, Maher ER. Molecular genetic tests in surgical management of familial adenomatous polyposis. Lancet 1997; 350: 1777.
16. Soravia C, Berk T, Cohen Z. Genetic testing and surgical decision making in hereditary colorectal cancer. Int J Colorectal Dis 2000; 15: 21-28.
17. Vasen HF, van der Luijt RB, Slors JF, Buskens E, de Ruiter P, Baeten CG et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996; 348: 433-435.
18. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 100: 612-620.
19. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R et al. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol 2006; 24: 1195-1203.
20. Janinis J, Patriki M, Vini L, Aravantinos G, Whelan JS. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 2003; 14: 181-190.
21. Smith AJ, Lewis JJ, Merchant NB, Leung DH, Woodruff JM, Brennan MF. Surgical management of intra-abdominal desmoid tumours. Br J Surg 2000; 87: 608-613.
22. Soravia C, Berk T, McLeod RS, Cohen Z. Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum 2000; 43: 363-369.
23. Sturt NJ, Phillips RK, Clark SK. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Cancer 2004; 101: 652.
24. Dunlop MG. Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002; 51(Suppl 5): V21-V27.